In a filing, Applied Therapeutics Inc revealed its 10% Owner ALEXANDRIA REAL ESTATE EQUITIE unloaded Company’s shares for reported $0.64 million on Jun 05 ’24. In the deal valued at $4.24 per share,150,000 shares were sold. As a result of this transaction, ALEXANDRIA REAL ESTATE EQUITIE now holds 5,855,077 shares worth roughly $27.34 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, ALEXANDRIA REAL ESTATE EQUITIE sold 150,000 shares, generating $631,500 in total proceeds. Upon selling the shares at $4.21, the 10% Owner now owns 6,005,077 shares.
Before that, Shendelman Shoshana sold 318,573 shares. Applied Therapeutics Inc shares valued at $1,717,108 were divested by the President and CEO at a price of $5.39 per share. As a result of the transaction, Shendelman Shoshana now holds 3,817,814 shares, worth roughly $17.83 million.
RBC Capital Mkts initiated its Applied Therapeutics Inc [APLT] rating to an Outperform in a research note published on March 26, 2024; the price target was $12. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in late February with a ‘”an Outperform”‘ rating. Barclays also remained covering APLT and has decreased its forecast on January 04, 2022 with a “an Equal weight” recommendation from previously “an Overweight” rating. Goldman revised its rating on August 27, 2021. It rated APLT as “a Sell” which previously was an “a Neutral”.
Price Performance Review of APLT
On Friday, Applied Therapeutics Inc [NASDAQ:APLT] saw its stock jump 3.78% to $4.67. Over the last five days, the stock has gained 9.11%. Applied Therapeutics Inc shares have risen nearly 39.40% since the year began. Nevertheless, the stocks have risen 222.07% over the past one year. While a 52-week high of $9.39 was reached on 02/28/24, a 52-week low of $1.18 was recorded on 01/08/24. SMA at 50 days reached $4.76, while 200 days put it at $3.56. A total of 0.74 million shares were traded, compared to the trading of 0.57 million shares in the previous session.
Levels Of Support And Resistance For APLT Stock
The 24-hour chart illustrates a support level at 4.46, which if violated will result in even more drops to 4.24. On the upside, there is a resistance level at 4.87. A further resistance level may holdings at 5.06. The Relative Strength Index (RSI) on the 14-day chart is 57.54, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.26, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 19.92%. Stochastics %K at 70.07% indicates the stock is a holding.
